Showing 2 posts of 2 posts found.
The Colombian government has lowered the price of Glivec (imatinib) by 44%, a cancer drug made by Novartis. The case …
According to new findings from GlobalData, the Colombian pharmaceutical market is due to grow from $5 billion in 2015 to …
How will biomarker-led diagnostics reshape respiratory medicine?
Five Facts about COPD
“That gap between innovation and delivery was what stood out to me most”
Agentic commercial: how AI creates dialogue with HCPs and patients to help medicines reach them faster
Fortysomethings’ non-attendance at NHS Health Checks raises concerns, says study